Multiple drug hypersensitivity syndrome (Q49167): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Síndrome de hipersensibilidade a múltiplas drogas é definida como alergia a duas ou mais drogas quimicamente diferentes. Difere de reatividade cruzada (devida a semelhanças estruturais, vias metabólicas comuns ou mecanismos farmacológicos), reações de agudização (exacerbação de uma alergia a droga preexistente por troca precoce de terapia para uma nova droga), e síndrome de intolerância múltipla a drogas. | |||||||||||||||
| description / en | description / en | ||||||||||||||
Multiple drug hypersensitivity syndrome is defined as drug allergies to two or more chemically different drugs. It differs from cross-reactivity (due to structural similarities, common metabolic pathways, or pharmacological mechanisms), flare- up reactions (exacerbation of an existing drug allergy by the early switch of therapy to a novel drug), and multiple drug intolerance syndrome. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/1936492387 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:4A85.04 | |||||||||||||||
| Property / CURIE: CID11:4A85.04 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-4A85.04 | |||||||||||||||
| Property / Canary Token: dki-india-4A85.04 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: T78.4 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 19:29, 13 August 2026
Multiple drug hypersensitivity syndrome is defined as drug allergies to two or more chemically different drugs. It differs from cross-reactivity (due to structural similarities, common metabolic pathways, or pharmacological mechanisms), flare- up reactions (exacerbation of an existing drug allergy by the early switch of therapy to a novel drug), and multiple drug intolerance syndrome.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 4A85.04 |
||
| English | Multiple drug hypersensitivity syndrome |
Multiple drug hypersensitivity syndrome is defined as drug allergies to two or more chemically different drugs. It differs from cross-reactivity (due to structural similarities, common metabolic pathways, or pharmacological mechanisms), flare- up reactions (exacerbation of an existing drug allergy by the early switch of therapy to a novel drug), and multiple drug intolerance syndrome. |
Statements
CID11:4A85.04
0 references
dki-india-4A85.04
0 references
Concluído
0 references
13 August 2026
0 references
